Company intelligence / Profile preview

Nemaura Pharma

Loughborough, England, United Kingdom

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Nemaura Pharma developed multiple minimally invasive skin-based drug delivery platforms and reported an internal pipeline including pre-clinical and clinical-stage programs and at least one ANDA filing for a blockbuster drug, but there is no public evidence of late-stage (Phase 3 or commercial) proprietary therapeutics; its primary value appears to have been as a technology and formulation partner for pharma rather than as an independent drug sponsor.[1][4]

Therapeutic areas: EndocrinologyOtherMetabolic Disorders
Modalities: DeviceSmall moleculeBiologicNanoparticle
Industry: Biotech

Partnerships

Undisclosed global pharmaceutical companies and biotechnology companies for reformulation and drug delivery collaborations[1][4]

Beyond the preview

Go deeper on Nemaura Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nemaura Pharma.

Explore the full profile